18:0 PE-DTPA (Gd )

Code: 791275p-5mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

18:0 PE-DTPA (Gd) has been used: as a component of Gadolinium-liposome preparation in the nanodics preparation for nuclear magnetic resonance (NMR) studiesin cons...


en savoir plus

Votre prix
£178.00 5MG
£213.60 inc. VAT

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

18:0 PE-DTPA (Gd) has been used: as a component of Gadolinium-liposome preparation in the nanodics preparation for nuclear magnetic resonance (NMR) studiesin construction of cysteine-arginine-glutamic acid-lysine alanine (CREKA) based peptide amphiphile micelles (PAMs) for the magnetic resonance imaging (MRI) studies as a spin-labeled lipid for supported lipid bilayer incorporation for cryo transmission electron microscopy studies

Biochem/physiol Actions

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-diethylenetriaminepentaacetic acid (gadolinium salt) (18:0 PE-DTPA (Gd)) phospholipid based liposomes are useful in magnetic resonance imaging (MRI) and multimodal imaging. Apart from being a MRI contrast agent, PE-DTPA (Gd) liposome is also flexible for modification for binding different targets using copper–free click–chemistry methodology.

General description

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-diethylenetriaminepentaacetic acid (gadolinium salt) (18:0 PE-DTPA (Gd)) are sparing soluble in alcohol and well soluble in a solvent mixture consisting of chloroform and methanol in the ratio of 4:1, v/v. 18:0 PE-DTPA (Gd) is a synthetic phospholipid derivative ethanolamine. The DTPA is attached to gadolinium ion.

Packaging

5 mL Amber Glass Screw Cap Vial (791275P-5mg)

assay>99% (TLC)
formpowder
manufacturer/tradenameAvanti Polar Lipids 791275P
packagingpkg of 1 × 5 mg (791275P-5mg)
shipped indry ice
storage temp.−20°C
Ce produit répond aux critères suivants: